Overview

The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section

Status:
Completed
Trial end date:
2019-09-02
Target enrollment:
Participant gender:
Summary
Compare 0.05 μg/kg/min Norepinephrine and 0.25 μg/kg/min phenylephrine effect on fetus and parturient during Cesarean Section
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
China International Neuroscience Institution
Treatments:
Norepinephrine
Oxymetazoline
Phenylephrine